Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Platzbecker

Showing results (21-30 of 482) with videos related to

Pageof 49
Sort By:
Blood|April 25, 2022
Inflammation and myeloid malignancy: quenching the flameRyan J Stubbins, Uwe Platzbecker, Aly Karsan
Blood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe Platzbecker
Leukemia|May 11, 2018
Management of patients with acute promyelocytic leukemiaSabine Kayser, Richard F Schlenk, Uwe Platzbecker
Hemasphere|February 3, 2025
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapiesUwe Platzbecker, Richard A Larson, Sandeep Gurbuxani
Clinical Lymphoma, Myeloma & Leukemia|November 16, 2020
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of RelapseGeorg-Nikolaus Franke, Philipp Lückemeier, Uwe Platzbecker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Integrating the "Immunome" in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial DesignSusann Winter, Saeed Shoaie, Shahram Kordasti, et al.
Expert Review of Clinical Immunology|May 19, 2010
Stem cell transplantation for patients with Evans syndromeMartin Benesch, Christian Urban, Uwe Platzbecker, et al.
Genes|January 8, 2025
MicroRNA Screening Reveals Upregulation of FoxO-Signaling in Relapsed Acute Myeloid Leukemia PatientsPaula Reichelt, Stephan Bernhart, Uwe Platzbecker, et al.
British Journal of Haematology|July 25, 2003
Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cellsUwe Platzbecker, Jessica L Ward, H Joachim Deeg
Expert Review of Hematology|November 15, 2011
Optimizing management of myelodysplastic syndromes post-allogeneic transplantationKatja Sockel, Gerhard Ehninger, Lorenz C Hofbauer, et al.
Pageof 49

Showing results (21-30 of 482) with videos related to

Sort By:
Pageof 49
Blood|April 25, 2022
Inflammation and myeloid malignancy: quenching the flameRyan J Stubbins, Uwe Platzbecker, Aly Karsan
Blood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe Platzbecker
Leukemia|May 11, 2018
Management of patients with acute promyelocytic leukemiaSabine Kayser, Richard F Schlenk, Uwe Platzbecker
Hemasphere|February 3, 2025
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapiesUwe Platzbecker, Richard A Larson, Sandeep Gurbuxani
Clinical Lymphoma, Myeloma & Leukemia|November 16, 2020
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of RelapseGeorg-Nikolaus Franke, Philipp Lückemeier, Uwe Platzbecker
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Integrating the "Immunome" in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial DesignSusann Winter, Saeed Shoaie, Shahram Kordasti, et al.
Expert Review of Clinical Immunology|May 19, 2010
Stem cell transplantation for patients with Evans syndromeMartin Benesch, Christian Urban, Uwe Platzbecker, et al.
Genes|January 8, 2025
MicroRNA Screening Reveals Upregulation of FoxO-Signaling in Relapsed Acute Myeloid Leukemia PatientsPaula Reichelt, Stephan Bernhart, Uwe Platzbecker, et al.
British Journal of Haematology|July 25, 2003
Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cellsUwe Platzbecker, Jessica L Ward, H Joachim Deeg
Expert Review of Hematology|November 15, 2011
Optimizing management of myelodysplastic syndromes post-allogeneic transplantationKatja Sockel, Gerhard Ehninger, Lorenz C Hofbauer, et al.
Pageof 49